Basilea Pharmaceutica AG Market Cap

Basilea Pharmaceutica AG has a market cap or net worth of $753.83 million as of June 18, 2025. Its market cap has increased by 29.11% in one year.

Market Cap

753.83M

Enterprise Value

742.76M

Revenue

230.13M

Ranking

n/a

PE Ratio

8.80

Stock Price

$57.70

Market Cap Chart

Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 418.27M to 753.83M, an increase of 80.22%. That is a compound annual growth rate of 2.81%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	753.83M	36.42%
Dec 30, 2024	552.59M	10.03%
Dec 29, 2023	502.22M	-14.92%
Dec 30, 2022	590.31M	11.34%
Dec 30, 2021	530.19M	-18.41%
Dec 30, 2020	649.82M	25.05%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Elite Pharmaceuticals	790.52M
Veradigm	747.25M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
CytoDyn	437.04M
Glass House Brands	398.13M
Northwest Biotherapeutics	388.59M

Market Cap Rankings